p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis

被引:0
|
作者
Medina, D [1 ]
Kittrell, FS [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Limited hormonal stimulation of the mammary gland during a critical window in postpubertal development imparts a long-lasting protective effect against breast cancer in humans and in rodent models. The hormonal stimulation can be achieved by full-term pregnancy or low doses of estradiol-17beta and progesterone administered for 21 days. The mechanism(s) behind this effect of hormones is not understood at the molecular level. The experiments reported here demonstrate that the absence of p53 tumor suppressor gene function abrogates the protective effect of hormones against carcinogen-induced mammary carcinogenesis in BALB/c mice. This is the first identification of a specific gene product that mediates the protective effect of hormones. Additionally, the experiments highlight the usefulness of transgenic mouse models in the testing of hypotheses derived from the classic rat mammary models.
引用
收藏
页码:6140 / 6143
页数:4
相关论文
共 50 条
  • [1] The gain of function of p53 cancer mutant in promoting mammary tumorigenesis
    Lu, X.
    Liu, D. P.
    Xu, Y.
    ONCOGENE, 2013, 32 (23) : 2900 - 2906
  • [2] The gain of function of p53 cancer mutant in promoting mammary tumorigenesis
    X Lu
    D P Liu
    Y Xu
    Oncogene, 2013, 32 : 2900 - 2906
  • [3] Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability
    McCormack, SJ
    Weaver, Z
    Deming, S
    Natarajan, G
    Torri, J
    Johnson, MD
    Liyanage, M
    Ried, T
    Dickson, RB
    ONCOGENE, 1998, 16 (21) : 2755 - 2766
  • [4] Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability
    Stephen J McCormack
    Zoë Weaver
    Sandy Deming
    Geraldine Natarajan
    Jeff Torri
    Michael D Johnson
    Marek Liyanage
    Thomas Ried
    Robert B Dickson
    Oncogene, 1998, 16 : 2755 - 2766
  • [5] Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland
    A P L Smith
    M Henze
    J A Lee
    K G Osborn
    J M Keck
    D Tedesco
    D M Bortner
    M P Rosenberg
    S I Reed
    Oncogene, 2006, 25 : 7245 - 7259
  • [6] Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland
    Smith, A. P. L.
    Henze, M.
    Lee, J. A.
    Osborn, K. G.
    Keck, J. M.
    Tedesco, D.
    Bortner, D. M.
    Rosenberg, M. P.
    Reed, S. I.
    ONCOGENE, 2006, 25 (55) : 7245 - 7259
  • [7] CELL PROLIFERATIVE ACTIVITY AND P53 OVERACCUMULATION IN PRENEOPLASTIC AND EARLY NEOPLASTIC STAGES OF MOUSE MAMMARY TUMORIGENESIS
    NADJI, M
    HERBERT, L
    LOPEZ, DM
    MORALES, AR
    LABORATORY INVESTIGATION, 1994, 70 (01) : A19 - A19
  • [8] Role of the Rb and p53 Tumor Suppressor Pathways in Mammary Tumorigenesis
    Jones, R. A.
    Liu, J. C.
    Zhe, J.
    Schimmer, A. A.
    Eldad, Z.
    CANCER RESEARCH, 2012, 72
  • [9] Prolactin cooperates with loss of p53 to promote mammary tumorigenesis.
    O'Leary, K. A.
    Sullivan, R.
    Rugowski, D. E.
    Schuler, L. A.
    CANCER RESEARCH, 2012, 72
  • [10] Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models
    Rajkumar, Lakshmanaswamy
    Kittrell, Frances S.
    Guzman, Raphael C.
    Brown, Powel H.
    Nandi, Satyabrata
    Medina, Daniel
    BREAST CANCER RESEARCH, 2007, 9 (01)